Diametric Capital, LP Abb Vie Inc. Transaction History

Diametric Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $2.66 Million - $3.33 Million	-36,843 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$62.98 - $75.72 $2.32 Million - $2.79 Million	36,843 New	36,843 $2.75 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $1.44 Million - $1.93 Million	-15,640 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $1.4 Million - $1.54 Million	15,640	15,640 $1.51 Million

3,849

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $323B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Diametric Capital, LP with notifications on news.